Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2004;94:776-784
Published online before print February 12, 2004, doi: 10.1161/01.RES.0000121105.72718.5C
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
94/6/776    most recent
01.RES.0000121105.72718.5Cv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zeiffer, U.
Right arrow Articles by Weber, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zeiffer, U.
Right arrow Articles by Weber, C.
Related Collections
Right arrow Restenosis
Right arrow Pathophysiology
Right arrow Other Vascular biology
(Circulation Research. 2004;94:776.)
© 2004 American Heart Association, Inc.


Molecular Medicine

Neointimal Smooth Muscle Cells Display a Proinflammatory Phenotype Resulting in Increased Leukocyte Recruitment Mediated by P-Selectin and Chemokines

Ute Zeiffer, Andreas Schober, Michael Lietz, Elisa A. Liehn, Wolfgang Erl, Neil Emans, Zhong-qun Yan, Christian Weber

From the Departments of Molecular Cardiovascular Research (U.Z., A.S., M.L., E.L, C.W.) and Cardiology (A.S., C.W.) and from the Institute for Molecular Biotechnology (N.E.); University of Technology, Aachen, Germany; Institute for Prevention of Cardiovascular Diseases (W.E.), Ludwig-Maximilians-University, Munich, Germany, and Center for Molecular Medicine (Z.-q.Y.), Karolinska Institute, Stockholm, Sweden.

Correspondence to Dr Christian Weber, Kardiovaskuläre Molekularbiologie, Universitätsklinikum Aachen, Pauwelsstrasse 30, 52074 Aachen, Germany. E-mail cweber{at}ukaachen.de


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowMaterials and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Leukocyte recruitment is crucial for the response to vascular injury in spontaneous and accelerated atherosclerosis. Whereas the mechanisms of leukocyte adhesion to endothelium or matrix-bound platelets have been characterized, less is known about the proadhesive role of smooth muscle cells (SMCs) exposed after endothelial denudation. In laminar flow assays, neointimal rat SMCs (niSMCs) supported a 2.5-fold higher arrest of monocytes and "memory" T lymphocytes than medial SMCs, which was dependent on both P-selectin and VLA-4, as demonstrated by blocking antibodies. The increase in monocyte arrest on niSMCs was triggered by the CXC chemokine GRO-{alpha} and fractalkine, whereas "memory" T cell arrest was mediated by stromal cell–derived factor (SDF)-1{alpha}. This functional phenotype was paralleled by a constitutively increased mRNA and surface expression of P-selectin and of relevant chemokines in niSMCs, as assessed by real-time PCR and flow cytometry. The increased expression of P-selectin in niSMCs versus medial SMCs was associated with enhanced NF-{kappa}B activity, as revealed by immunofluorescence staining for nuclear p65 in vitro. Inhibition of NF-{kappa}B by adenoviral I{kappa}B{alpha} in niSMCs resulted in a marked reduction of increased leukocyte arrest in flow. Furthermore, P-selectin expression by niSMCs in vivo was confirmed in a hypercholesterolemic mouse model of vascular injury by double immunofluorescence and by RT-PCR after laser microdissection. In conclusion, we have identified a NF-{kappa}B–mediated proinflammatory phenotype of niSMCs that is characterized by increased P-selectin and chemokine expression and thereby effectively supports leukocyte recruitment.


Key Words: restenosis • inflammation • cell adhesion molecules • smooth muscle cells • chemokines


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowMaterials and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
The recruitment of leukocytes plays a major role in the response to vascular injury in atherosclerosis and restenosis.1,2 Monocytes are recruited to sites of endothelial denudation and neointimal hyperplasia, eg, after balloon angioplasty, especially in association with hypercholesterolemia.3 Monocyte-derived macrophages contribute significantly to neointimal plaque area and express multiple growth factors, cytokines, and enzymes involved in neointimal growth.1,3 Although the mechanisms of the initial leukocyte adhesion to inflamed endothelium or to matrix-bound platelets emulating the early phase after endothelial denudation have been thoroughly investigated,4 less is known about a proadhesive role of neointimal smooth muscle cells (niSMCs) in mononuclear cell recruitment.

Neointimal SMCs differ from medial SMCs in many ways, eg, in their morphology, proliferative potential, and gene expression, and exhibit a phenotype resembling fetal SMCs.5 Early reports show that modified niSMCs can permanently replace endothelial cells in extensively denuded vessels.6,7 Because neointimal growth is attenuated or even terminated after reendothelialization,1,8 niSMCs exposed to circulating blood could be an important component in the progression of neointimal hyperplasia, eg, by amplifying monocyte recruitment. Activation of NF-{kappa}B in niSMCs lining the vessel wall has been found to occur after balloon injury of rat carotid arteries and to be accompanied by enhanced expression of VCAM-1 and monocyte chemotactic protein (MCP)-1, which may mediate monocyte infiltration.9 This may further corroborate the hypothesis that activated niSMCs can form a pseudoendothelium and thus contribute to leukocyte recruitment.

We investigated whether niSMCs differ from medial SMCs in their expression pattern of genes instrumental in monocyte recruitment representing a distinct proinflammatory phenotype and explored the contribution of NF-{kappa}B to the regulation of this phenotype. In this study, we show that niSMCs exhibit a constitutively enhanced expression of P-selectin, CC, and CXC chemokines, and thereby support increased monocyte and "memory" T-cell arrest in flow, resembling the proadhesive phenotype of activated endothelial cells. This phenotype appeared to be attributable to an enhanced constitutive NF-{kappa}B activity in niSMCs.


*    Materials and Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Materials and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Cell Culture and Cell Separation
SMCs were isolated from media and neointima of adult Sprague-Dawley rats as described.10 Neointimal cells were obtained by microscopic dissection of the neointimal layer from thoracic aortas 2 weeks after balloon injury. Medial SMCs were obtained from uninjured thoracic aortas. SMCs were grown in Dulbecco’s modified Eagle’s medium-F12 (Life Technologies, containing 10% FCS, penicillin/streptavidin). Experiments were performed between passages 6 and 14; equivalent passages of medial and neointimal cells were compared in each set of experiment. SMC phenotype was confirmed by positive immunostaining for SMC-specific {alpha}-actin ({alpha}-SMA, clone 1A4, DAKO) in 99% of cultured cells. Mono Mac6 cells were cultured as described.11 CD4+CD45RO+ T lymphocytes were isolated from peripheral blood mononuclear cells by negative selection using immunomagnetic separation (Miltenyi Biotec).12

Monocyte and CD4+CD45RO+ T-Cell Adhesion on SMCs in Shear Flow
Laminar flow assays were performed as described.11–14 Rat neointimal and medial SMCs were preincubated with or without polyclonal P-selectin antibody (5 µg/mL; cross-reacts with rat P-selectin, Pharmingen), polyclonal fractalkine Ab (20 µg/mL, R&D Systems), polyclonal MCP-1 Ab (20 µg/mL, Pharmingen), or control Abs, for 15 minutes at 37°C. For some experiments SMCs were pretreated with TNF-{alpha} (105 U/mL, PeproTech) overnight. MonoMac6 cells or CD4+CD45RO+ T cells (0.5x106/mL) in assay buffer (10 mmol/L HEPES, 1 mmol/L Ca2+/Mg2+, and 0.5% bovine serum albumin) were perfused at 1.5 dyne/cm2. For inhibition experiments these cells were preincubated with VLA-4 mAb (10 µg/mL, clone HP1/2), ß2-integrin mAb (10 µg/mL, clone TS1/18), CXCR4 mAb (10 µg/mL, clone 12G5, Pharmingen), isotype control, or 8-73GRO-{alpha} (1 µg/mL, donated by Dr I. Clark-Lewis, University of British Columbia) at 37°C for 15 minutes. Firm cell adhesion and rolling (>1 second) after 2 minutes were analyzed in multiple high-power fields recorded by video microscopy.

RNA Isolation and Real-Time Quantitative RT-PCR Analysis
Total RNA (2 µg) was isolated from 7x106 SMCs (RNeasy, Qiagen) and reverse-transcribed. The following primers were used: ß-actin forward, 5'-AGAGGGAAATCGTGCGTGAC-3'; reverse, 5'-CGATAGTGATGACCTGACCGT-3' (138 bp). P-selectin forward, 5'-CAATAAGACTCTCACGGCGGAGGC-3'; reverse, 5'-CAGGTGTAGCTCCCAATGGTCTCG-3' (231 bp). VCAM-1 forward, 5'-GGCTACATCCACACTGACGCTGAG-3'; reverse, 5'-CCCTTCAGTAGTTCAATCTCCAGATGG-3' (240 bp). GRO-{alpha} forward, 5'-GCACCCAAACCGAAGTCATA-3'; reverse, 5'-GCCATCGGTGCAATCTATCT-3' (146 bp); SDF-1{alpha} forward, 5'-GGACGCCAAGGTCGTCGCCGTG-3'; reverse, 5'-TCGGGTCAATGCACAC-3' (222 bp).

For quantitative real-time reverse transcription-polymerase chain reaction (RT-PCR), a standard for each primer set was generated by cloning PCR products in pBluescript. A 2-µL cDNA sample was incubated with 25 µL QuantiTect Mix containing fluorescence dye SYBR Green (Qiagen) and 0.6 µmol/L of each primer pair. PCR amplification was performed after initial denaturation at optimized annealing temperatures for each primer pair using MJ Research Opticon 2 (Biozym). Melting curves were acquired by stepwise increase of the temperature from 55°C to 95°C. Crossing points (CPs) of real-time PCR curves were determined by Opticon Monitor software. The difference of the CPs ({Delta}CP) of target and ß-actin control reflected the amount of target mRNA in each sample. Target mRNA was quantified according to standard curve and normalized to levels of ß-actin.

Flow Cytometry
For detection of chemokines on the cell surface, confluent medial SMCs and niSMCs were trypsinized, washed, and reacted with fractalkine Ab (R&D Systems), GRO-{alpha} Ab (PeproTech), SDF-1{alpha} mAb (R&DSystems), or control Abs for 30 minutes at 4°C. Surface P-selectin was analyzed after fixation with 1% paraformaldehyde (PFA), containing 2% glucose and 0.02% NaN3 and incubation with polyclonal P-selectin Ab (Pharmingen) or control Ab. Subsequently, cells were stained with fluorescein isothiocyanate (FITC)–conjugated secondary Abs and analyzed by flow cytometry (FACSCalibur, BD Biosciences).

Atherogenic Mouse Model of Restenosis
Carotid arteries of apolipoprotein E–deficient (apoE–/–) mice (M&B, Ry, Denmark) on high-cholesterol diet were injured as described (n=3).13 In brief, mice were anesthetized with intraperitoneal ketamine/xylazine and after midline neck incision, the left external carotid artery was tied off distally, and via transverse arteriotomy, a 0.014 in flexible angioplasty guide wire was advanced by 1 cm. Endothelial denudation was achieved by three passes along the common carotid artery with a rotating motion. Two weeks after injury arteries were perfusion-fixed with 4% PFA and embedded in paraffin. Animal experiments were approved by local authorities and complied with German animal protection law.

Double Immunofluorescence Microscopy
Carotid artery sections (5 µm, three sections per mouse) were incubated with polyclonal P-selectin Ab (Pharmingen) or an irrelevant rabbit IgG overnight at 4°C. Antibody binding was detected with a biotinylated secondary Ab and alkaline phosphatase-avidin complex (Vectastain ABC-AP kit) visualized with Vector Red Substrate kit (all from Vector Labs). Subsequently {alpha}-SMA staining was performed with 1A4 mAb (2 µg/mL) followed by a FITC-labeled secondary Ab. Incubation with polyclonal p50 Ab (Santa Cruz) for 24 hours at 4°C was performed after antigen retrieval using a citrate buffer (pH 6, with 0.05% Tween20, 10 minutes in a microwave oven). Ab binding was detected by a biotinylated secondary Ab and avidin-FITC (all Vector labs). Finally, sections were mounted and analyzed by fluorescence microscopy (Leica DMLB microscope).

SMCs were cultured on chamber slides (Falcon) until confluence. After methanol fixation (5 minutes, –30°C) double immunofluorescence staining for P-selectin (polyclonal P-selectin Ab, Pharmingen) and {alpha}-SMA (1A4) was performed essentially as described earlier. Combined p65 and P-selectin immunostaining was performed with a polyclonal p65 Ab (Santa Cruz) for 1 hour, reacted with a biotinylated secondary Ab and avidin-FITC. Subsequently staining for P-selectin was performed with a polyclonal P-selectin Ab (Santa Cruz), detected by a biotinylated secondary Ab and avidin-TRITC (Sigma).

Laser Microdissection and PCR Analysis
Microdissection of neointimal tissue was performed on 5-µm–thick paraffin embedded sections of the common carotid artery 2 weeks after wire injury. After immunostaining for {alpha}-SMA (clone 1A4) and counterstaining with hematoxylin, {alpha}-SMA–positive cells were microdissected from the center of neointimal lesions using a laser micromanipulator (PALM MicroBeam). Whole carotid arteries were used as controls. Microdissected cells were directly transferred into reaction tubes containing RNA stabilization reagent (RNAlater, Qiagen), and RNA was isolated (RNeasy Micro kit, Qiagen). Total RNA was reversed-transcribed using Oligo-dT primers (Sensiscript RT Qiagen). Specific products were amplified by PCR (QuantiTect Probe PCR kit, Qiagen, Tann=55°C, 45 cycles) with primers for P-selectin (forward, 5'-CTTTGGTCCGAACACCACTT-3', reverse, 5'-CTAGGTGGCTGTGAGGGTTC-3'; 214 bp) and VE-cadherin (forward, 5'-ACCGGATGACCAAGTACAGC-3', reverse, 5'-TTCTGGTTTTCTGGCAGCTT-3'; 292 bp) and separated with a 2% agarose gel.

Overexpression of Adenoviral-Encoded I{kappa}B-{alpha}
Construction of the adenoviral vector encoding for I{kappa}B-{alpha} (rAD.I{kappa}B-{alpha}; a kind gift from Dr R. de Martin, Vienna International Research Center, Austria) and adenoviral gene transfer were performed as described.15 Briefly, subconfluent SMCs were washed with PBS and incubated at a multiplicity of infection (MOI) of 500 (plaque forming units, PFU) with rAD.I{kappa}B-{alpha} or control adenovirus encoding the ß-Galactosidase protein (rAD.lacZ) in medium without FCS. After 1 hour at 37°C, the adenovirus was washed off and fresh growth medium was added. To analyze the efficiency of transduction, rAD.lacZ-infected SMCs were stained with X-Gal after 48 hours and the percentage of ß-Gal–positive SMCs was determined by bright-field microscopy (60.5±8.7%, n=4).

Gel Shift Analysis
Nuclear protein (10 µg) was isolated from untreated niSMCs or from niSMCs 24 hours after adenoviral gene transfer as previously described.15 After incubation for 15 minutes with [32P]-dATP-labeled, double-stranded oligonucleotides corresponding to the NF-{kappa}B binding motif 5'-AGTTGAGGGGACTTTCCCAGGC-3' (Santa Cruz), samples were separated on nondenaturing 4% polyacrylamide gels and exposed to x-ray films.

Statistical Analysis
Data are expressed as mean±SD unless otherwise stated. Statistical analysis was performed with Prism Software (Graph Pad) by use of two-tailed Student’s t test or one-way ANOVA and Newman-Keuls post test. Differences with P<0.05 were considered as statistically significant.


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMaterials and Methods
*Results
down arrowDiscussion
down arrowReferences
 
Medial SMCs have been shown to support efficient monocyte adhesion in stasis only when stimulated with cytokines or modified lipoproteins.16 Less is known about the adhesive properties of niSMCs, which display a phenotype distinct from medial SMCs and become exposed to circulating leukocytes after endothelial denudation. Hence, we compared the propensity of niSMCs and medial SMCs without cytokine stimulation to recruit monocytes under flow conditions. Rolling of monocytes as a prerequisite for firm arrest in the adhesion cascade17 was observed on niSMCs, but was barely detectable on medial SMCs (Figure 1A). The shear-resistant arrest of monocytic cells on niSMCs was 2.5-fold higher than that supported by resting medial SMCs (Figure 1B). Stimulation with TNF-{alpha} increased monocyte arrest on both neointimal and medial SMCs to almost equivalent levels (data not shown).



View larger version (33K):
[in this window]
[in a new window]
 
Figure 1. Increased monocyte and memory T-cell recruitment on niSMCs compared with medial SMCs in flow. Neointimal and medial SMCs were pretreated with blocking Abs to P-selectin, fractalkine, MCP-1, or left untreated (control), and monocytic cells or CD4+CD45RO+ cells were pretreated with or without CXCR2 antagonist 8-73GRO-{alpha}, VLA-4 mAb, or CXCR4 mAb as indicated. Leukocytes were perfused at 1.5 dyne/cm2, and the number of rolling or firmly adherent cells was determined. Increased monocyte rolling on niSMCs depends on P-selectin and VLA-4 (A), *P<0.01. P-selectin increases VLA-4–mediated monocyte arrest on niSMCs (B), *P<0.01. Chemokines GRO-{alpha} and fractalkine, but not MCP-1 or the SDF-1{alpha} receptor CXCR4 contribute to monocyte arrest on niSMCs (C), *P<0.01 vs control. Increased arrest of CD4+CD45RO+ T cells on niSMCs depends on VLA-4 and CXCR4 (D), *P<0.01. Data are mean±SD from at least 3 independent experiments.

We next explored whether adhesion molecules involved in monocyte recruitment on endothelium also participate in monocyte arrest on SMCs. Pretreatment of SMCs with a blocking P-selectin Ab markedly inhibited monocyte rolling and arrest on niSMCs but did not affect adhesive interactions on medial SMCs (Figures 1A and 1B). Blocking VLA-4, the monocytic receptor for VCAM-1, almost completely abolished monocyte rolling and arrest on niSMCs and medial SMCs (Figures 1A and 1B). In contrast, blocking monocyte ß2-integrins had no effect (data not shown). Thus, monocyte rolling and arrest on SMCs is generally dependent on VLA-4, whereas the substantial enhancement of monocyte arrest on niSMCs is mediated by P-selectin. Chemokines and their receptors are crucial for triggering integrin-dependent arrest of monocytes on inflamed or atherosclerotic endothelium.11,18 Accordingly, monocyte arrest on niSMCs was significantly decreased by pretreatment of monocytes with the GRO-{alpha}/KC receptor CXCR2 antagonist 8-73GRO-{alpha} (by almost 50%) or by pretreatment of niSMCs with a blocking mAb to fractalkine (Figure 1C). In contrast, blocking MCP-1 or the SDF-1{alpha} receptor CXCR4 on monocytes did not significantly affect monocyte arrest (Figure 1C). Thus, CXCR2 and fractalkine rather than MCP-1 and SDF-1{alpha} appear to be involved in triggering VLA-4–mediated monocyte arrest on niSMCs.

A role of CD4+CD45RO+ memory T cells in the formation of atherosclerotic plaques has been described.19 Hence, we tested whether niSMCs can also recruit memory T cells in flow. Compared with medial SMCs, niSMCs supported a significantly enhanced arrest of CD4+CD45RO+ T cells, which was inhibited by blocking T-cell VLA-4 (Figure 1D). Unlike monocyte arrest on niSMCs, enhanced VLA-4–mediated memory T-cell arrest could be abolished by pretreatment with the CXCR4 mAb (Figure 1D), indicating that it was triggered by SDF-1{alpha}.

To provide a molecular basis for the remarkable difference in the adhesive phenotype between the distinct SMC subtypes, we next investigated the expression of relevant adhesion molecules and chemokines by quantitative real-time RT-PCR (Figure 2 and online Figure 1 available in the online data supplement at http://circres.ahajournals.org). In line with the functional differences, the expression of P-selectin mRNA was hardly detectable in medial SMCs, but substantially upregulated (>2.5-fold) in niSMCs (Figure 2). Accordingly, the expression of GRO-{alpha} and SDF-1{alpha} transcripts was 3-fold and 2-fold higher in niSMCs compared with medial SMCs (Figure 2). In contrast, differences in VCAM-1 expression between niSMCs and medial SMCs were negligible (Figure 2), indicating that the differential expression of P-selectin and chemokines was sufficient to explain differences in VLA-4–mediated arrest. In extension to mRNA expression analysis, we studied surface expression of the functionally relevant proteins by flow cytometry. Surface expression of P-selectin was restricted to a SMC subset (Figures 3A and 3E), which was expanded among niSMCs (65±15%, n=3, Figure 3E) compared with medial SMCs (30±7%, n=3, Figure 3A). Furthermore, surface P-selectin was increased on the P-selectin–positive subset of niSMCs (Figure 3E). Double immunofluorescence staining for P-selectin and {alpha}-SMA confirmed expression of P-selectin on niSMCs and medial SMCs (online Figure 2). The surface expression of fractalkine was slightly enhanced on niSMCs (Figure 3F) compared with medial SMCs (Figure 3B). The presence of immobilized GRO-{alpha} (Figures 3C and 3G and online Figure 3) and SDF-1-{alpha} (Figures 3D and 3H) on the cell surface, a prerequisite for their role as arrest chemokines, was not evident in medial SMCs (Figures 3C and 3D), but clearly detectable on niSMCs (Figures 3G and 3H). In contrast to GRO-{alpha} and SDF-1-{alpha}, the CC chemokine MCP-1 was not immobilized on the surface of SMCs, albeit upregulation of MCP-1 in niSMCs was found by ELISA of SMC lysates (online Figure 4). Thus, the functional differences between SMC phenotypes were attributable to changes in their gene expression profile, which account for increased surface expression of proteins relevant for leukocyte arrest.



View larger version (22K):
[in this window]
[in a new window]
 
Figure 2. Differential mRNA expression of P-selectin, GRO-{alpha}, and SDF-1{alpha} in neointimal and medial SMCs as assessed by quantitative real-time PCR. P-selectin, GRO-{alpha}, and SDF-1{alpha} mRNA expression normalized to ß-actin is significantly increased in niSMCs, whereas VCAM-1 is not differentially expressed. Data are mean±SD from at least 3 independent experiments. *P<0.05.



View larger version (14K):
[in this window]
[in a new window]
 
Figure 3. Flow cytometry analysis of P-selectin (A and E), fractalkine (B and F), GRO-{alpha} (C and G), and SDF-1{alpha} (D and H) surface levels on SMCs. Representative histogram plots of control Ab staining (filled) and antigen-specific Ab (bold) of medial SMCs (top) and niSMCs (bottom) are shown. P-selectin surface expression on medial (A) and neointimal SMCs (E) is restricted to a subset of SMCs, which was expanded among neointimal SMCs. Enhanced surface expression of fractalkine (B and F), GRO-{alpha} (C and G), and SDF-1{alpha} (D and H) were detected on niSMCs compared with medial SMCs.



View larger version (33K):
[in this window]
[in a new window]
 
Figure 4. A, Immunofluorescence staining for p65 in niSMCs and medial SMCs in vitro. Nuclear translocation of p65 was rarely evident in medial SMCs, whereas a significant population of niSMCs revealed nuclear p65 staining (indicated by asterisks). Scale bars=50 µm. B, Combined immunofluorescence staining for p65 (green) and P-selectin (red) demonstrates P-selectin expression predominantly in niSMCs with nuclear p65 staining. Scale bar=20 µm.

In accordance with the notion that the induction of genes, such as GRO-{alpha} and P-selectin, involves the transcription factor NF-{kappa}B, a gene array analysis confirmed that in addition to cell cycle–associated genes, a cluster of NF-{kappa}B–dependent transcripts for chemokines and adhesion molecules was upregulated in niSMCs versus media SMCs (U. Zeiffer and C. Weber, unpublished data, 2004). This prompted us to analyze whether NF-{kappa}B was also involved in establishing the neointimal SMC phenotype.20 Nuclear translocation of the Rel family protein p65 as a marker for NF-{kappa}B activity was determined by immunofluorescence staining in vitro. Compared with medial SMCs where p65 was rarely detected in the nucleus (3±1.3% n=7, Figure 4A), the proportion of niSMCs with nuclear p65 was substantial (35±4%, n=11, Figure 4A). Furthermore P-selectin expression was exclusively evident in niSMCs with nuclear p65, as determined by combined immunofluorescence staining, suggesting a correlation of NF-{kappa}B activity and P-selectin expression (Figure 4B).

To ultimately demonstrate the direct contribution of the enhanced constitutive NF-{kappa}B activity to the niSMC phenotype, adenovirus-mediated transfer of the NF-{kappa}B inhibitor I{kappa} B-{alpha} was performed. Electrophoretic mobility shift assays demonstrated DNA binding of NF-{kappa}B after gene transfer with the control adenovirus rAD.lacZ (Figure 5A), which was comparable to the binding activity in untreated niSMCs and constituted of two DNA-protein complexes that is p50/p65 heterodimer and p50 homodimer as identified by supershift analysis (data not shown). Overexpression of I{kappa}B-{alpha} resulted in a complete inhibition of p65/p50 heterodimer binding to its consensus sequence in niSMCs (Figure 5A). This inhibition in DNA binding of NF-{kappa}B by I{kappa}B-{alpha} overexpression was associated with a marked reduction of the increased arrest of monocytes (Figure 5B) and CD4+ CD45RO+ T cells (Figure 5C) on niSMCs.



View larger version (50K):
[in this window]
[in a new window]
 
Figure 5. Effect of I{kappa}B-{alpha} overexpression in niSMCs. A, Electromobility shift assays were performed to detect NF-{kappa}B DNA binding activity in niSMCs after adenoviral transfer of the lacZ reporter gene (rAD.lacZ) or the I{kappa}B-{alpha} gene (rAD.I{kappa}B-{alpha}). Autoradiography of 4 independent samples per group is shown. Monocyte (B) and CD4+CD45RO+ T cells (C) arrest on niSMCs after infection with rAD.I{kappa}B-{alpha} or control virus (rAD.lacZ) was determined under flow conditions. Number of adherent cells was expressed as the percentage of that in untreated controls. Data are mean±SD from at least 3 independent experiments. *P<0.05.

To evaluate the role of niSMCs expressing P-selectin in vivo, neointimal lesions of apoE–/– mice 2 weeks after carotid wire injury were studied by immunofluorescence staining for {alpha}-SMA and P-selectin. It has been described that up to 25% of the denuded area is not covered by endothelial cells 2 weeks after carotid wire injury.21 In this neointimal area devoid of endothelium, P-selectin–expressing SMCs were detected at the luminal lining, forming a pseudoendothelium (Figure 6A). In neointimal sections where reendothelialization was established, P-selectin–expressing SMCs were regularly found in deeper neointimal layers (Figure 6B). To verify the transcriptional upregulation of P-selectin in niSMCs, RT-PCR analysis was performed in microdissected {alpha}-SMA–positive cells derived from neointimal lesions. Although {alpha}-SMA staining ensured positive identification of niSMCs, VE-cadherin mRNA expression was analyzed as a marker for potential contamination of the samples with endothelial cells. In {alpha}-SMA+/VE-cadherin neointimal cells, P-selectin expression was clearly evident (Figure 6C), thereby identifying neointimal SMCs as a source of P-selectin in vivo. Finally, immunofluorescence staining for p50 in vivo revealed nuclear translocation of p50 in the majority of neointimal cells, including luminal cells, with a distribution resembling P-selectin expression 2 weeks after wire-induced injury (Figure 6D). Solely cytoplasmic p50 was detectable in sections from uninjured carotid arteries (online Figure 5). This further implicates enhanced NF-{kappa}B activity as a crucial regulator controlling the niSMC phenotype.



View larger version (61K):
[in this window]
[in a new window]
 
Figure 6. P-selectin expression in neointimal SMCs 2 weeks after wire-induced carotid injury in apoE–/– mice. P-selectin–expressing neointimal SMCs constitute the luminal lining in areas of the neointimal lesion which is not reendothelialized (A). In areas of neointimal lesions covered by endothelial cells double immunofluorescence staining for {alpha}-SMA (green) and P-selectin (red) revealed P-selectin protein expression in the majority of neointimal SMCs (B). Scale bars=20 µm, arrows indicate internal elastic lamina. C, PCR analysis of microdissected {alpha}-SMA–positive neointimal cells revealed P-selectin mRNA expression. Contamination with endothelial cells was excluded by the absence of VE-cadherin mRNA expression in the neointimal samples. Complete carotid artery samples served as control. D, Nuclear translocation of p50 was evident by immunofluorescence staining in the vast majority of neointimal cells 2 weeks after wire injury. To demonstrate, nuclear p50 sections were counterstained with DAPI. Scale bars=20 µm.


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMaterials and Methods
up arrowResults
*Discussion
down arrowReferences
 
In this study we have found that cultured niSMCs display a proadhesive phenotype that is characterized by increased leukocyte recruitment and associated with a constitutive upregulation of P-selectin and the chemokines GRO-{alpha}, SDF-1{alpha}, and fractalkine. P-selectin and GRO-{alpha} markedly enhanced VLA-4–dependent monocyte adhesion to niSMCs under flow conditions, whereas the SDF-1{alpha} receptor CXCR4 selectively mediated the arrest of memory T cells via VLA-4. In addition, the pronounced surface expression of fractalkine on niSMCs supported monocyte recruitment, conceivably via integrin-independent mechanisms.22 This proinflammatory phenotype appears to be the functional consequence of enhanced constitutive NF-{kappa}B activity in niSMCs, as indicated by the reduction of increased leukocyte arrest after inhibition of NF-{kappa}B activity. Upregulation of P-selectin expression was confined to a subset of niSMCs, in which P-selectin was diffusely distributed on the cell surface. In vivo, SMCs expressing P-selectin and SMCs exhibiting constitutive NF-{kappa}B activity could be found in deeper neointimal layers, as well as contributing to the luminal lining of neointimal lesions 2 weeks after arterial injury in apoE–/– mice.

Studies in apoE–/– mice have shown that the absence of P-selectin reduces aortic lesions by 40% to 62%, an effect that is attributable to diminished macrophage infiltration.23,24 Indeed, blocking P-selectin inhibits monocyte rolling and adhesion on early atherosclerotic lesions in carotid arteries of apoE–/– mice.25 After wire-induced endothelial denudation in apoE–/– mice, neointima formation and macrophage recruitment were almost completely prevented in the absence of P-selectin, revealing an even more substantial involvement of P-selectin.26 In contrast to spontaneous atherosclerosis, the expression of P-selectin has been detected in media and developing neointima after carotid ligation,27 but its functional implications have not been elucidated. Because endothelial denudation with subsequent neointima formation results in the exposure of niSMCs to the blood stream before reendothelialization is accomplished, P-selectin on niSMCs may serve to support monocyte recruitment. We could confirm an upregulation of P-selectin in niSMCs compared with uninjured medial SMCs. The enhanced expression of P-selectin was involved in increased monocyte rolling and arrest on niSMCs in flow, by serving as a prerequisite for firm arrest via VLA-4,17 by triggering VLA-4 avidity alone,28 or in synergy with chemokines. Because P-selectin–expressing SMCs were identified along the luminal lining and in directly subluminal portions of the arterial neointima, this may represent a SMC phenotype with the propensity to establish a pseudoendothelium after denudation.6,7,9

Like endothelial cells, vascular SMCs can become a potent source for different chemokines, eg, MCP-1 or interleukin-8 on stimulation with inflammatory cytokines.29 Chemokines and their receptors, which can exhibit specialized functions in the multistep process of leukocyte recruitment,11,17,30 have been implicated in the progression of atherosclerosis and restenosis.13,31,32 Interestingly, we found that various chemokines involved in atherogenic monocyte recruitment were constitutively upregulated in niSMCs. For instance, GRO-{alpha}, which triggers VLA-4–dependent monocyte adhesion to early atherosclerotic lesions,18 is expressed and immobilized on the surface of niSMCs and stimulates VLA-4–mediated monocyte arrest on niSMCs in flow. Conversely, the enhanced expression of SDF-1{alpha} in niSMCs did not contribute to monocyte arrest, which is in accordance to in vivo results in apoE–/– mice after carotid wire-injury, demonstrating that treatment with a neutralizing antibody to SDF-1{alpha} had no effect on neointimal macrophage content.33 On the other hand, the dramatic increase in VLA-4–dependent arrest of proatherogenic CD4+CD45RO+ T cells involved SDF-1{alpha}, as shown by blocking its receptor CXCR4. This finding suggests that different SMC-derived chemokines cooperate in the regulation of subtype-specific leukocyte recruitment. Furthermore, surface expression of fractalkine was upregulated on niSMCs and a neutralizing fractalkine Ab reduced monocyte arrest under flow conditions. Fractalkine can mediate monocyte adhesion to endothelial cells in an integrin-independent fashion22 and therefore may participate in monocyte recruitment on niSMCs by a similar and distinctive mechanism. In apoE–/– mice, lesional SMCs express fractalkine, particularly in the vicinity of macrophages,32 implying a role of SMC-derived fractalkine in macrophage infiltration in atherosclerosis. Our data indicate that this role may extend to neointimal monocyte recruitment after endothelial denudation.

The proadhesive phenotype of niSMCs was accompanied by an increased constitutive nuclear translocation of p50/p65 proteins. In contrast to endothelial cells, where NF-{kappa}B is transiently activated by cytokines, a constitutive and sustained NF-{kappa}B activation has been described in SMCs in vitro34 and in vivo,9 presumably due to a divergent NF-{kappa}B regulation.34 Furthermore, NF-{kappa}B DNA binding activity in SMCs was increased up to 14 days after arterial injury in a rat model, concurrently with monocyte adhesion to luminal niSMCs.9 Because the transcription of multiple inflammatory genes upregulated in niSMCs, eg, P-selectin, GRO-{alpha}, MCP-1, and fractalkine,35–37 is controlled by NF-{kappa}B, this transcription factor might integrate the intracellular signals finally leading to neointimal leukocyte recruitment. The finding that inhibition of NF-{kappa}B activity by overexpression of I{kappa}B-{alpha} diminished leukocyte arrest in vitro supports the concept that NF-{kappa}B is centrally involved in generating the proadhesive phenotype of niSMCs. This hypothesis is further substantiated by the correlation of P-selectin expression and NF-{kappa}B activity in vitro and in vivo. Surprisingly, the expression of VCAM-1 was comparable in niSMCs and medial SMCs. This is consistent with findings that VCAM-1 gene expression during differentiation of cultured SMCs was independent of NF-{kappa}B38 and that the upregulation of neointimal expression after arterial injury in vivo was transient for VCAM-1 and prolonged for MCP-1, indicating a dissociation of their regulation.39 The sustained NF-{kappa}B activation and conversion into a proadhesive phenotype may occur either through persistence of stimulating agents, eg, by autocrine production of growth factors or cytokines,34 or through elements modifying the activation of the NF-{kappa}B signaling cascade, such as the I{kappa}B kinase activity.

The present characterization of a proadhesive phenotype with its molecular basis in niSMCs provides novel insights into their pathophysiological role, which may comprise the adoption of endothelial-like functions in luminal cell lining and inflammatory leukocyte recruitment during neointima formation. This may advance the identification of molecular targets selectively directed at niSMCs and their functions in the prevention of restenosis.


*    Acknowledgments
 
This study was supported by Deutsche Forschungsgemeinschaft grants We 1913-2/3 (C.W.) and by the "Interdisciplinary Center for Clinical Research on Biomaterials" (BMBF grant No. 01 KS 9503/9) (C.W.). We thank S. Knarren for excellent technical assistance.


*    Footnotes
 
Original received May 21, 2003; first resubmission received September 24, 2003; second resubmission received January 7, 2004; accepted January 29, 2004.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMaterials and Methods
up arrowResults
up arrowDiscussion
*References
 
1. Ferns GA, Avades TY. The mechanisms of coronary restenosis: insights from experimental models. Int J Exp Pathol. 2000; 81: 63–88.[CrossRef][Medline] [Order article via Infotrieve]

2. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med. 1999; 340: 115–126.[Free Full Text]

3. Danenberg HD, Fishbein I, Gao J, Monkkonen J, Reich R, Gati I, Moerman E, Golomb G. Macrophage depletion by clodronate-containing liposomes reduces neointimal formation after balloon injury in rats and rabbits. Circulation. 2002; 106: 599–605.[Abstract/Free Full Text]

4. Kuijper PH, Galla do Torres HI, Houben LA, Lammers JW, Zwaginga JJ, Koenderman L. P-selectin and MAC-1 mediate monocyte rolling and adhesion to ECM-bound platelets under flow conditions. J Leukoc Biol. 1998; 64: 467–473.[Abstract]

5. Schwartz SM, deBlois D, O’Brien ER. The intima: soil for atherosclerosis and restenosis. Circ Res. 1995; 77: 445–465.[Free Full Text]

6. Stemerman MB, Spaet TH, Pitlick F, Cintron J, Lejnieks I, Tiell ML. Intimal healing: the pattern of reendothelialization and intimal thickening. Am J Pathol. 1977; 87: 125–142.[Abstract]

7. Reidy MA. A reassessment of endothelial injury and arterial lesion formation. Lab Invest. 1985; 53: 513–520.[Medline] [Order article via Infotrieve]

8. Asahara T, Bauters C, Pastore C, Kearney M, Rossow S, Bunting S, Ferrara N, Symes JF, Isner JM. Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery. Circulation. 1995; 91: 2793–2801.[Abstract/Free Full Text]

9. Lindner V. The NF-{kappa}B and I{kappa} B system in injured arteries. Pathobiology. 1998; 66: 311–320.[CrossRef][Medline] [Order article via Infotrieve]

10. Yan Z, Hansson GK. Overexpression of inducible nitric oxide synthase by neointimal smooth muscle cells. Circ Res. 1998; 82: 21–29.[Abstract/Free Full Text]

11. Weber KS, von Hundelshausen P, Clark-Lewis I, Weber PC, Weber C. Differential immobilization and hierarchical involvement of chemokines in monocyte arrest and transmigration on inflamed endothelium in shear flow. Eur J Immunol. 1999; 29: 700–712.[CrossRef][Medline] [Order article via Infotrieve]

12. Weber C, Weber KS, Klier C, Gu S, Wank R, Horuk R, Nelson PJ. Specialized roles of the chemokine receptors CCR1 and CCR5 in the recruitment of monocytes and T(H)1-like/CD45RO(+) T cells. Blood. 2001; 97: 1144–1146.[Abstract/Free Full Text]

13. Schober A, Manka D, von Hundelshausen P, Huo Y, Hanrath P, Sarembock IJ, Ley K, Weber C. Deposition of platelet RANTES triggering monocyte recruitment requires P-selectin and is involved in neointima formation after arterial injury. Circulation. 2002; 106: 1523–1529.[Abstract/Free Full Text]

14. Zernecke A, Erl W, Fraemohs L, Lietz M, Weber C. Suppression of endothelial adhesion molecule upregulation with cyclopentenone prostaglandins is dissociated from I{kappa}B kinase inhibition and cell death induction. FASEB J. 2003; 17: 1099–1101.[Abstract/Free Full Text]

15. Erl W, Hansson GK, de Martin R, Draude G, Weber KS, Weber C. Nuclear factor-{kappa}B regulates induction of apoptosis and inhibitor of apoptosis protein-1 expression in vascular smooth muscle cells. Circ Res. 1999; 84: 668–677.[Abstract/Free Full Text]

16. Thorne SA, Abbot SE, Stevens CR, Winyard PG, Mills PG, Blake DR. Modified low density lipoprotein and cytokines mediate monocyte adhesion to smooth muscle cells. Atherosclerosis. 1996; 127: 167–176.[CrossRef][Medline] [Order article via Infotrieve]

17. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell. 1994; 76: 301–314.[CrossRef][Medline] [Order article via Infotrieve]

18. Huo Y, Weber C, Forlow SB, Sperandio M, Thatte J, Mack M, Jung S, Littman DR, Ley K. The chemokine KC, but not monocyte chemoattractant protein-1, triggers monocyte arrest on early atherosclerotic endothelium. J Clin Invest. 2001; 108: 1307–1314.[CrossRef][Medline] [Order article via Infotrieve]

19. Stemme S, Holm J, Hansson GK. T lymphocytes in human atherosclerotic plaques are memory cells expressing CD45RO and the integrin VLA-1. Arterioscler Thromb. 1992; 12: 206–211.[Abstract/Free Full Text]

20. De Martin R, Hoeth M, Hofer-Warbinek R, Schmid JA. The transcription factor NF-{kappa}B and the regulation of vascular cell function. Arterioscler Thromb Vasc Biol. 2000; 20: E83–E88.

21. Lindner V, Fingerle J, Reidy MA. Mouse model of arterial injury. Circ Res. 1993; 73: 792–796.[Abstract/Free Full Text]

22. Fong AM, Robinson LA, Steeber DA, Tedder TF, Yoshie O, Imai T, Patel DD. Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow. J Exp Med. 1998; 188: 1413–1419.[Abstract/Free Full Text]

23. Collins RG, Velji R, Guevara NV, Hicks MJ, Chan L, Beaudet AL. P-Selectin or intercellular adhesion molecule (ICAM)-1 deficiency substantially protects against atherosclerosis in apolipoprotein E-deficient mice. J Exp Med. 2000; 191: 189–194.[Abstract/Free Full Text]

24. Dong ZM, Brown AA, Wagner DD. Prominent role of P-selectin in the development of advanced atherosclerosis in ApoE-deficient mice. Circulation. 2000; 101: 2290–2295.[Abstract/Free Full Text]

25. Ramos CL, Huo Y, Jung U, Ghosh S, Manka DR, Sarembock IJ, Ley K. Direct demonstration of P-selectin- and VCAM-1-dependent mononuclear cell rolling in early atherosclerotic lesions of apolipoprotein E–deficient mice. Circ Res. 1999; 84: 1237–1244.[Abstract/Free Full Text]

26. Manka D, Collins RG, Ley K, Beaudet AL, Sarembock IJ. Absence of p-selectin, but not intercellular adhesion molecule-1, attenuates neointimal growth after arterial injury in apolipoprotein E–deficient mice. Circulation. 2001; 103: 1000–1005.[Abstract/Free Full Text]

27. Kumar A, Hoover JL, Simmons CA, Lindner V, Shebuski RJ. Remodeling and neointimal formation in the carotid artery of normal and P-selectin-deficient mice. Circulation. 1997; 96: 4333–4342.[Abstract/Free Full Text]

28. Yago T, Tsukuda M, Minami M. P-selectin binding promotes the adhesion of monocytes to VCAM-1 under flow conditions. J Immunol. 1999; 163: 367–373.[Abstract/Free Full Text]

29. Wang JM, Sica A, Peri G, Walter S, Padura IM, Libby P, Ceska M, Lindley I, Colotta F, Mantovani A. Expression of monocyte chemotactic protein and interleukin-8 by cytokine-activated human vascular smooth muscle cells. Arterioscler Thromb. 1991; 11: 1166–1174.[Abstract/Free Full Text]

30. Weber C. Novel mechanistic concepts for the control of leukocyte transmigration: specialization of integrins, chemokines, and junctional molecules. J Mol Med. 2003; 81: 4–19.[Medline] [Order article via Infotrieve]

31. Reape TJ, Groot PH. Chemokines and atherosclerosis. Atherosclerosis. 1999; 147: 213–225.[CrossRef][Medline] [Order article via Infotrieve]

32. Lesnik P, Haskell CA, Charo IF. Decreased atherosclerosis in CX3CR1–/– mice reveals a role for fractalkine in atherogenesis. J Clin Invest. 2003; 111: 333–340.[CrossRef][Medline] [Order article via Infotrieve]

33. Schober A, Knarren S, Lietz M, Lin EA, Weber C. Crucial role of stromal cell-derived factor-1{alpha} in neointima formation after vascular injury in apolipoprotein E–deficient mice. Circulation. 2003; 108: 2491–2497.[Abstract/Free Full Text]

34. Bourcier T, Sukhova G, Libby P. The nuclear factor {kappa}-B signaling pathway participates in dysregulation of vascular smooth muscle cells in vitro and in human atherosclerosis. J Biol Chem. 1997; 272: 15817–15824.[Abstract/Free Full Text]

35. Pan J, McEver RP. Regulation of the human P-selectin promoter by Bcl-3 and specific homodimeric members of the NF-{kappa}B/Rel family. J Biol Chem. 1995; 270: 23077–23083.[Abstract/Free Full Text]

36. Weber KS, Draude G, Erl W, de Martin R, Weber C. Monocyte arrest and transmigration on inflamed endothelium in shear flow is inhibited by adenovirus-mediated gene transfer of I{kappa}B-{alpha}. Blood. 1999; 93: 3685–3693.[Abstract/Free Full Text]

37. Garcia GE, Xia Y, Chen S, Wang Y, Ye RD, Harrison JK, Bacon KB, Zerwes HG, Feng L. NF-{kappa}B-dependent fractalkine induction in rat aortic endothelial cells stimulated by IL-1ß, TNF-{alpha}, and LPS. J Leukoc Biol. 2000; 67: 577–584.[Abstract]

38. Lavie J, Dandre F, Louis H, Lamaziere JM, Bonnet J. Vascular cell adhesion molecule-1 gene expression during human smooth muscle cell differentiation is independent of NF-{kappa}B activation. J Biol Chem. 1999; 274: 2308–2314.[Abstract/Free Full Text]

39. Bishop GG, McPherson JA, Sanders JM, Hesselbacher SE, Feldman MJ, McNamara CA, Gimple LW, Powers ER, Mousa SA, Sarembock IJ. Selective {alpha}vß3-receptor blockade reduces macrophage infiltration and restenosis after balloon angioplasty in the atherosclerotic rabbit. Circulation. 2001; 103: 1906–1911.[Abstract/Free Full Text]




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
E. Shagdarsuren, Y. Djalali-Talab, M. Aurrand-Lions, K. Bidzhekov, E. A. Liehn, B. A. Imhof, C. Weber, and A. Zernecke
Importance of Junctional Adhesion Molecule-C for Neointimal Hyperplasia and Monocyte Recruitment in Atherosclerosis-Prone Mice-Brief Report
Arterioscler Thromb Vasc Biol, August 1, 2009; 29(8): 1161 - 1163.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
L. Landsman, L. Bar-On, A. Zernecke, K.-W. Kim, R. Krauthgamer, E. Shagdarsuren, S. A. Lira, I. L. Weissman, C. Weber, and S. Jung
CX3CR1 is required for monocyte homeostasis and atherogenesis by promoting cell survival
Blood, January 22, 2009; 113(4): 963 - 972.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Schober
Chemokines in Vascular Dysfunction and Remodeling
Arterioscler Thromb Vasc Biol, November 1, 2008; 28(11): 1950 - 1959.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
E Lozano, M Segarra, A Garcia-Martinez, J Hernandez-Rodriguez, and M C Cid
Imatinib mesylate inhibits in vitro and ex vivo biological responses related to vascular occlusion in giant cell arteritis
Ann Rheum Dis, November 1, 2008; 67(11): 1581 - 1588.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. Chen, J. M. Abrahams, L. M. Smith, J. H. McVey, R. I. Lechler, and A. Dorling
Regenerative repair after endoluminal injury in mice with specific antagonism of protease activated receptors on CD34+ vascular progenitors
Blood, April 15, 2008; 111(8): 4155 - 4164.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
B. Liu, M. Han, and J.-K. Wen
Acetylbritannilactone Inhibits Neointimal Hyperplasia after Balloon Injury of Rat Artery by Suppressing Nuclear Factor-{kappa}B Activation
J. Pharmacol. Exp. Ther., January 1, 2008; 324(1): 292 - 298.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
E. Shagdarsuren, K. Bidzhekov, Y. Djalali-Talab, E. A. Liehn, M. Hristov, R. A. Matthijsen, W. A. Buurman, A. Zernecke, and C. Weber
C1-Esterase Inhibitor Protects Against Neointima Formation After Arterial Injury in Atherosclerosis-Prone Mice
Circulation, January 1, 2008; 117(1): 70 - 78.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. Krohn, U. Raffetseder, I. Bot, A. Zernecke, E. Shagdarsuren, E. A. Liehn, P. J. van Santbrink, P. J. Nelson, E. A. Biessen, P. R. Mertens, et al.
Y-Box Binding Protein-1 Controls CC Chemokine Ligand-5 (CCL5) Expression in Smooth Muscle Cells and Contributes to Neointima Formation in Atherosclerosis-Prone Mice
Circulation, October 16, 2007; 116(16): 1812 - 1820.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J.-J. Chiu, L.-J. Chen, C.-I Lee, P.-L. Lee, D.-Y. Lee, M.-C. Tsai, C.-W. Lin, S. Usami, and S. Chien
Mechanisms of induction of endothelial cell E-selectin expression by smooth muscle cells and its inhibition by shear stress
Blood, July 15, 2007; 110(2): 519 - 528.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Barlic, Y. Zhang, and P. M. Murphy
Atherogenic Lipids Induce Adhesion of Human Coronary Artery Smooth Muscle Cells to Macrophages by Up-regulating Chemokine CX3CL1 on Smooth Muscle Cells in a TNF{alpha}-NF{kappa}B-dependent Manner
J. Biol. Chem., June 29, 2007; 282(26): 19167 - 19176.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. Liu, S. Patil, M. Rojas, A. M. Fong, S. S. Smyth, and D. D. Patel
CX3CR1 Deficiency Confers Protection From Intimal Hyperplasia After Arterial Injury
Arterioscler Thromb Vasc Biol, September 1, 2006; 26(9): 2056 - 2062.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
T. Raj, P. Kanellakis, G. Pomilio, G. Jennings, A. Bobik, and A. Agrotis
Inhibition of Fibroblast Growth Factor Receptor Signaling Attenuates Atherosclerosis in Apolipoprotein E-Deficient Mice
Arterioscler Thromb Vasc Biol, August 1, 2006; 26(8): 1845 - 1851.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. Blindt, F. Vogt, I. Astafieva, C. Fach, M. Hristov, N. Krott, B. Seitz, A. Kapurniotu, C. Kwok, M. Dewor, et al.
A Novel Drug-Eluting Stent Coated With an Integrin-Binding Cyclic Arg-Gly-Asp Peptide Inhibits Neointimal Hyperplasia by Recruiting Endothelial Progenitor Cells
J. Am. Coll. Cardiol., May 2, 2006; 47(9): 1786 - 1795.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C.-N. Chen, S.-F. Chang, P.-L. Lee, K. Chang, L.-J. Chen, S. Usami, S. Chien, and J.-J. Chiu
Neutrophils, lymphocytes, and monocytes exhibit diverse behaviors in transendothelial and subendothelial migrations under coculture with smooth muscle cells in disturbed flow
Blood, March 1, 2006; 107(5): 1933 - 1942.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
G. Li, J. M. Sanders, E. T. Phan, K. Ley, and I. J. Sarembock
Arterial Macrophages and Regenerating Endothelial Cells Express P-Selectin in Atherosclerosis-Prone Apolipoprotein E-Deficient Mice
Am. J. Pathol., December 1, 2005; 167(6): 1511 - 1518.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
E. W. Raines and N. Ferri
Thematic Review Series: The Immune System and Atherogenesis. Cytokines affecting endothelial and smooth muscle cells in vascular disease
J. Lipid Res., June 1, 2005; 46(6): 1081 - 1092.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
C. Weber
Platelets and Chemokines in Atherosclerosis: Partners in Crime
Circ. Res., April 1, 2005; 96(6): 612 - 616.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
Q. Cai, L. Lanting, and R. Natarajan
Interaction of Monocytes With Vascular Smooth Muscle Cells Regulates Monocyte Survival and Differentiation Through Distinct Pathways
Arterioscler Thromb Vasc Biol, December 1, 2004; 24(12): 2263 - 2270.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
A. Schober, A. Zernecke, E. A. Liehn, P. von Hundelshausen, S. Knarren, W. A. Kuziel, and C. Weber
Crucial Role of the CCL2/CCR2 Axis in Neointimal Hyperplasia After Arterial Injury in Hyperlipidemic Mice Involves Early Monocyte Recruitment and CCL2 Presentation on Platelets
Circ. Res., November 26, 2004; 95(11): 1125 - 1133.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
C. Weber, A. Schober, and A. Zernecke
Chemokines: Key Regulators of Mononuclear Cell Recruitment in Atherosclerotic Vascular Disease
Arterioscler Thromb Vasc Biol, November 1, 2004; 24(11): 1997 - 2008.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
E. W. Raines, K. J. Garton, and N. Ferri
Beyond the Endothelium: NF-{kappa}B Regulation of Smooth Muscle Function
Circ. Res., April 2, 2004; 94(6): 706 - 708.
[Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
94/6/776    most recent
01.RES.0000121105.72718.5Cv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zeiffer, U.
Right arrow Articles by Weber, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zeiffer, U.
Right arrow Articles by Weber, C.
Related Collections
Right arrow Restenosis
Right arrow Pathophysiology
Right arrow Other Vascular biology